Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells.
about
Studies on anticancer activities of antimicrobial peptidesMilk metabolites and neurodegeneration: Is there crosstalk?Dietary proteins and angiogenesisMilk proteins, peptides, and oligosaccharides: effects against the 21st century disordersCapillary sprout endothelial cells exhibit a CD36 low phenotype: regulation by shear stress and vascular endothelial growth factor-induced mechanism for attenuating anti-proliferative thrombospondin-1 signalingSmall lytic peptides escape the inhibitory effect of heparan sulfate on the surface of cancer cells.PGPIPN, a therapeutic hexapeptide, suppressed human ovarian cancer growth by targeting BCL2.Lactoferrin Reduces Chorioretinal Damage in the Murine Laser Model of Choroidal Neovascularization.Lactoferricin B inhibits the phosphorylation of the two-component system response regulators BasR and CreB.Bovine lactoferricin is anti-inflammatory and anti-catabolic in human articular cartilage and synoviumLactoferricin mediates anti-inflammatory and anti-catabolic effects via inhibition of IL-1 and LPS activity in the intervertebral disc.Proteomic profiling in early venous stenosis formation in a porcine model of hemodialysis graftHealth-Related Aspects of Milk Proteins.In vitro antioxidative potential of lactoferrin and black tea polyphenols and protective effects in vivo on carcinogen activation, DNA damage, proliferation, invasion, and angiogenesis during experimental oral carcinogenesis.Roles of lactoferrin on skin wound healing.Antimicrobial peptides: versatile biological properties.Metronomic chemotherapy and anti-angiogenesis: can upgraded pre-clinical assays improve clinical trials aimed at controlling tumor growth?Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptides.Immune modulation by multifaceted cationic host defense (antimicrobial) peptides.Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use.The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis.Archetypal tryptophan-rich antimicrobial peptides: properties and applications.Effects of macrophage metalloelastase on the basic fibroblast growth factor expression and tumor angiogenesis in murine colon cancer.Attenuation of massive cytokine response to the staphylococcal enterotoxin B superantigen by the innate immunomodulatory protein lactoferrin.Antibacterial activity of synthetic peptides derived from lactoferricin against Escherichia coli ATCC 25922 and Enterococcus faecalis ATCC 29212.Potential anticarcinogenic peptides from bovine milk.Effect of non-anticoagulant N-desulfated heparin on basic fibroblast growth factor expression, angiogenesis, and metastasis of gastric carcinoma in vitro and in vivo.Lactoferricin enhances BMP7-stimulated anabolic pathways in intervertebral disc cells.Comparison of the effect between pegaptanib and ranibizumab on exudative age-related macular degeneration with small lesion size.SL15: A seminal plasma-derived lectin from the sperm of llama (Lama glama).Bioactive compounds from crocodile (Crocodylus siamensis) white blood cells induced apoptotic cell death in hela cells.
P2860
Q24650885-D5DE22E0-3177-4FF7-850B-4ADDCE12124AQ26777352-473F5354-9ED0-4918-B312-6AE53761FF6DQ27013908-4340F6B6-F106-49F9-92A5-2953B59FEF9BQ27023113-7B4E7A8A-5D12-48E9-8C65-70C83F852874Q28581719-568D41F6-A02A-40D7-A84C-255EE1C30DF5Q33858892-BE0647FA-8A05-4E56-B503-D74EC78CCF27Q34673854-3B5C8201-09D8-4390-BD5C-F47B9C43D14AQ35593031-B06EFDD7-443A-4BF2-9BF7-95996B83E3EEQ35878781-913174BE-2D24-4364-ACE7-1CD53D27228AQ36295868-52112D33-912E-4276-8B26-71579F41CA96Q36987580-77B9D0C2-3B17-45BE-A778-4971013E9A77Q37184382-96D356E4-96A8-45C1-890C-044BDEB01257Q37491375-BC2DA19F-E9B6-429A-99E1-5F93F742E9B8Q37681906-A9EC7F3C-D83A-40E2-A01F-4FEF8A8B0B7BQ37983906-59A28BFC-7D95-4D8E-8A83-5EBF1A4B11DFQ38128298-3A75A3D0-C769-45D3-8ADF-32E06570E571Q38155883-564965FF-429B-4154-B678-22E4C2DE8C8CQ38160482-54701448-C13C-4E0D-99BA-50FB2031C56DQ38162670-A649A87C-0E83-45ED-A88D-E69F8955C1D1Q38418286-C1A869B0-9C74-4A7E-9D71-8BFA626B4932Q38540713-594D0899-4E97-41AF-B8A0-8F03B1D5D974Q38691301-06DBA816-120F-4C6C-A650-4BDCB9318960Q39495473-B718FDEC-2897-47A8-BF97-E3A76D975467Q39816086-2B994DA0-8AFF-4B5B-B3FE-23CF7A3B1C85Q41150225-57A2E7CB-6EEB-4F94-9ED1-03226460BAE2Q41865936-0A83BE86-03AB-4360-BD14-D6C239471973Q41900600-AF42618D-A8CE-4C2B-922C-8F0115F8D372Q42124492-7914EA9C-7350-4FE4-AD9D-D4284A676A6FQ42129632-B75273AE-8CBE-4F94-A625-64760BEC3799Q48277263-7BBEB92C-D875-4D5D-B55D-6F9462B72931Q53605330-05EAD81B-D710-469E-8AAD-784D580EAEFC
P2860
Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Bovine lactoferricin inhibits ...... ng sites on endothelial cells.
@en
Bovine lactoferricin inhibits ...... ng sites on endothelial cells.
@nl
type
label
Bovine lactoferricin inhibits ...... ng sites on endothelial cells.
@en
Bovine lactoferricin inhibits ...... ng sites on endothelial cells.
@nl
prefLabel
Bovine lactoferricin inhibits ...... ng sites on endothelial cells.
@en
Bovine lactoferricin inhibits ...... ng sites on endothelial cells.
@nl
P2093
P2860
P1476
Bovine lactoferricin inhibits ...... ing sites on endothelial cells
@en
P2093
Daniel Smyth
David W Hoskin
Jamie S Mader
P2860
P304
P356
10.2353/AJPATH.2006.051229
P407
P577
2006-11-01T00:00:00Z